Physician profile
Patrick J Butler
NPI 1316057516
$6,204.55
in general payments reported to CMS, 2019-2025
23 companies · $14.34 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,517 · 2020: $1,053 · 2021: $822 · 2022: $576 · 2023: $603 · 2024: $619 · 2025: $14.34.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,237.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,236.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,587.53 | 2019-2024 | Clareon, Rocklatan |
| Allergan, INC. | $1,047.14 | 2019-2022 | |
| Carl Zeiss Meditec, INC. | $607.66 | 2019-2020 | |
| New World Medical,INC. | $426.36 | 2019-2020 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $210.10 | 2020-2021 | |
| Abbvie INC. | $175.15 | 2023-2024 | Lumigan, Alphagan P, Vuity |
| Sun Pharmaceutical Industries INC. | $137.00 | 2019-2024 | Cequa |
| Novo Nordisk INC | $125.00 | 2024 | Wegovy |
| Shire North American Group INC | $118.67 | 2019 | |
| Bausch & Lomb Americas INC. | $117.57 | 2022-2024 | Vyzulta, Miebo, Prolensa |
| Sight Sciences, INC. | $92.37 | 2020 | |
| Kerecis Limited | $89.18 | 2022 | |
| Aerie Pharmaceuticals, INC. | $87.36 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $75.00 | 2021 | |
| Kala Pharmaceuticals, INC. | $65.06 | 2019-2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $62.68 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $53.24 | 2023 | Tecnis Iol |
| Thea Pharma INC. | $34.16 | 2023-2024 | Iyuzeh |
| Biotissue Holdings INC. | $29.85 | 2019-2020 | |
| Oyster Point Pharma, INC. | $21.84 | 2022 | |
| Abbott Laboratories | $14.34 | 2025 | Navitor |
| Novartis Pharmaceuticals Corporation | $13.83 | 2019 | |
| Tearlab Corp | $13.46 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Butler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.